The UK is home to the globally respected regulator, the Medicines & Healthcare Products Regulatory Agency, and its dedicated Innovation Ofﬁce. This helps MedTech organisations to navigate the regulatory processes, and frequently processes clinical investigations in 60 days.
There is a significant focus on single-use technology, orthopaedic devices and in vitro diagnostics. The service and supply chain for medical technologies provides essential support, including design, manufacturing and regulatory expertise. The fastest growing segments of the UK industry by revenue are medical imaging, in vitro diagnostics and drug delivery and, by employment, digital health, drug delivery and single-use technology.
Right: Genomics Plc – A UK Success Story
Companies in the region include:
a global leader in the glucose monitoring market, which grew out of the acquisition of the Oxford University spin-out company, Medisense and now produces over 2 billion glucose test strips annually at its production facility in Witney, Oxfordshire.
a second Oxford University spin-out, which has developed the world’s first and only nanopore DNA sequencer, the MinION. The company aims to become the world’s leading producer of equipment to decode the DNA of any organism, from people to viruses.
The region is also the chosen location for many medical device companies with operations across the range of R&D, sales and service and manufacturing, including:
a US owned global medical device company which has demonstrated its commitment to the Thames Valley by consolidating its Oxford and Basingstoke sites in new premises at Winnersh Triangle, near Reading.